The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178: 7849-7858.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, H.-K.
Right arrow Articles by Datta, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, H.-K.
Right arrow Articles by Datta, S. K.

Low-Dose Peptide Tolerance Therapy of Lupus Generates Plasmacytoid Dendritic Cells That Cause Expansion of Autoantigen-Specific Regulatory T Cells and Contraction of Inflammatory Th17 Cells1,2

Hee-Kap Kang, Michael Liu and Syamal K. Datta3

Division of Rheumatology, Departments of Medicine and Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611

Subnanomolar doses of an unaltered, naturally occurring nucleosomal histone peptide epitope, H471–94, when injected s.c. into lupus-prone mice, markedly prolong lifespan by generating CD4+25+ and CD8+ regulatory T cells (Treg) producing TGF-beta. The induced Treg cells suppress nuclear autoantigen-specific Th and B cells and block renal inflammation. Splenic dendritic cells (DC) captured the s.c.-injected H471–94 peptide rapidly and expressed a tolerogenic phenotype. The DC of the tolerized animal, especially plasmacytoid DC, produced increased amounts of TGF-beta, but diminished IL-6 on stimulation via the TLR-9 pathway by nucleosome autoantigen and other ligands; and those plasmacytoid DC blocked lupus autoimmune disease by simultaneously inducing autoantigen-specific Treg and suppressing inflammatory Th17 cells that infiltrated the kidneys of untreated lupus mice. Low-dose tolerance with H471–94 was effective even though the lupus immune system is spontaneously preprimed to react to the autoepitope. Thus, H471–94 peptide tolerance therapy that preferentially targets pathogenic autoimmune cells could spare lupus patients from chronically receiving toxic agents or global immunosuppressants and maintain remission by restoring autoantigen-specific Treg cells.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Institutes of Health (R37-AR39157 and R01-AI41985) and the Solovy Arthritis Research Society (to S.K.D.) and the Arthritis National Research Foundation (to H.-K.K.).

2 Preliminary results on the mechanism of low-dose peptide tolerance were presented as an abstract at the 2005 Annual Meeting of the American College of Rheumatology, Basic Research Conference, San Diego, CA, November 12–17 (H.-K. Kang, M. Liu, and S. K. Datta, 2005. Arthritis Rheum. 52:S32, Abstract BRC4).

3 Address correspondence and reprint requests to Dr. Syamal K. Datta, Division of Rheumatology, Feinberg School of Medicine, Northwestern University, 240 East Huron Street, McGaw No. M300, Chicago, IL 60611. E-mail address: skd257{at}northwestern.edu

4 Abbreviations used in this paper: MHC II, MHC class II; DC, dendritic cell; pDC, plasmacytoid DC; T reg, regulatory T cell; IDO, indoleamine 2,3 dioxygenase; MFI, mean fluorescence intensity.




This article has been cited by other articles:


Home page
LupusHome page
A La Cava
T-regulatory cells in systemic lupus erythematosus
Lupus, May 1, 2008; 17(5): 421 - 425.
[Abstract] [PDF]


Home page
LupusHome page
S. Datta and C Mauri
Signalling defects and cellular interactions (2)
Lupus, March 1, 2008; 17(3): 247 - 250.
[PDF]


Home page
J. Immunol.Home page
R. P. Singh, A. La Cava, and B. H. Hahn
pConsensus Peptide Induces Tolerogenic CD8+ T Cells in Lupus-Prone (NZB x NZW)F1 Mice by Differentially Regulating Foxp3 and PD1 Molecules
J. Immunol., February 15, 2008; 180(4): 2069 - 2080.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.